Differing expression of MMPS-1 and -9 and urokinase receptor between diffuse- and intestinal-type gastric carcinoma

International Journal of Cancer

Volumn 84, Issue 1, 1999, Pages 74-79

  Migita, Takashi ^a   Sato, Eiichi ^a   Saito, Kazuya ^a   Mizoi, Takayuki ^a   Shiiba, Ken Ichi ^a   Matsuno, Seiki ^a   Nagura, Hiroshi ^a   Ohtani, Haruo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE B; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; STROMA;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; COLLAGENASES; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; RECEPTORS, CELL SURFACE; STOMACH NEOPLASMS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032957227     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990219)84:1<74::AID-IJC14>3.0.CO;2-I     Document Type: Article

References (22)

1. ALLGAYER, H., BABLIC, R., BEYER, B.C.M., GRUTZNER, K.U., TARABICHI, A., SCHILDBERG, F.W. and HEISS, M.M., Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer. Oncology, 55, 152-160 (1998).
2. COCKETT, M.I., MURPHY, G., BIRCH, M.L., O'CONNELL, J.P., CRABBE, T., MILLICAN, A.T., HART, I.R. and DOCHERTY, A.J., Matrix metalloproteinases and metastatic cancer. Biochem. Soc. Symp., 63, 295-313 (1998).
3. DANØ, K., ANDREASEN, P.A., GRØNDAHL-HANSEN, J., KRISTENSEN, P., NIELSEN, L.S. and SKRIVER, L., Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res., 44, 139-266 (1985).
4. GILLES, C., PILETTE, M., SEIKI, M., BIREMBAUT, P. and THOMPSON, E.W., Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest., 76, 651-660 (1997).
5. GRESS, T.M., Müller-PILLASCH, F., LERCH, M.M., FRIESS, H., BÜHLER, M. and ADLER, G., Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer, 62, 407-413 (1995).
6. GRØNDAHL-HANSEN, J., CHRISTENSEN, I.J., ROSENQUIST, C., BRUNNER, N., MOURIDSEN, H.T., DANØ, K. and BLICHERT-TOFT, M., High level of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res., 53, 2513-2521 (1993).
7. GRØNDAHL-HANSEN, J., RALFKIAER, E., KIRKEBY, L.T., KRISTENSEN, P., LUND, L.R. and DANØ, K., Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Amer. J. Pathol., 138, 111-117 (1991).
8. GUIFORD, P., HOPKINS, J., HARRAWAY, J., MCLEOD, M., MCLEOD, N., HARAWIRA, P., TAITE, H., SCOULAR, R., MILLER, A. and REEVE, A.E., E-cadherin germline mutations in familial gastric cancer. Nature (Lond.), 392, 402-405 (1998).
9. HEPPNER, K.J., MATRISIAN, L.M., JENSEN, R.A. and RODGERS, W.H., Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Amer. J. Pathol., 149, 273-282 (1996).
10. LAUREN, P., The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta pathol. microbiol. Scand., 64, 31-49 (1965).
11. MAEDA, S., SAWAI, T., UZUKI, M., TAKAHASHI, Y., OMOTO, H., SEKI, M. and SAKURAI, M., Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann. Rheum. Dis., 54, 970-975 (1995).
12. NAGASE, H., Activation mechanisms of matrix metalloproteinases. Biol. Chem., 378, 151-160 (1997).
13. NEKARDA, H., SCHMITT, M., ULM, K., WENNINGER, A., VOGELSANG, H., BECKER, K., RODER, J.D., FINK, U. and SIEWERT, J.R., Prognosis impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res., 54, 2900-2907 (1994).
14. OHTANI, H., Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions. Pathol. Int., 48, 1-9 (1998).
15. OHTANI, H., MOTOHASHI, H., SATO, H., SEIKI, M. and NAGURA, H., Dual expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int. J. Cancer, 67, 1-6 (1996).
16. OHTANI, H., NAITO, Y., SAITO, K. and NAGURA, H., Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: a possible anti-tumor immunity? Lab. Invest., 77, 231-243 (1997).
17. PYKE, C., GRAEM, N., RALFKIAER, E., RONNE, E., HOYER-HANSEN, G., BRUNNER, N. and DANØ, K., Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res., 53, 1911-1915 (1993).
18. SAKURAI, Y., OTANI, Y., KAMEYAMA, K., HOSODA, Y., OKAZAKI, I., KUMAI, K. and KITAJIMA, M., Expression of interstitial collagenase (matrix metalloproteinase-1) in gastric cancers. Jpn. J. Cancer Res., 88, 401-406 (1997).
19. SATO, H., OKADA, Y. and SEIKI, M., Membrane-type metalloproteinases (MT-MMPs) in cell invasion. Thrombosis Haemostasis, 78, 497-500 (1997).
20. STETLER-STEVENSON, W.G., AZNAVOORIAN, S. and LIOTTA, L.A., Tumor cell interaction with the extracellular matrix during invasion and metastasis. Ann. Rev. Cell Biol., 9, 541-573 (1993).
21. SUGANO, H., NAKAMURA, K. and KATO, Y., Pathological studies of human gastric cancer. Acta. Pathol. Jpn., 32, 329-347 (1982).
22. TAKEHA, S., FUJIYAMA, Y., BAMBA, T., SORSA, T., NAGURA, H. and OHTANI, H., Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect. Jpn. J. Cancer Res., 88, 72-81 (1997).